INS and type 1 diabetes mellitus: Elevated expressions of kininogen-1 respectively prekallikrein (cleaves kininogen to vasoactive peptide bradykinin) have also previously been described in type 1 diabetic patients and rats38–40, which in rats further could be reversed with insulin treatment40.